Works matching DE "ANTIBE Therapeutics Inc."

Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis.

Published in:

British Journal of Pharmacology, 2007, v. 150, n. 8, p. 996, doi. 10.1038/sj.bjp.0707193

By:

• Fiorucci, S;
• Orlandi, S;
• Mencarelli, A;
• Caliendo, G;
• Santagada, V;
• Distrutti, E;
• Santucci, L;
• Cirino, G;
• Wallace, J L

Publication type:

Article